Radioactive Iodine Therapy: Who Needs It? (2026 Guide)

Radioactive iodine therapy is considered when there is a risk of recurrence after total thyroidectomy, or when iodine-avid metastasis has been confirmed — it is not something every thyroid cancer patient needs.

Key Takeaways

• Radioactive iodine (RAI) therapy uses the thyroid cell's ability to absorb iodine to destroy any remaining tissue and micrometastases after surgery.
• If recurrence risk is low, RAI is usually skipped; it becomes a consideration for intermediate-risk and higher-risk groups.
• Before treatment, a low-iodine diet and a period of isolated inpatient stay may be required.
• Common side effects include dry mouth, salivary gland swelling, altered taste, and nausea — all part of the typical general course.
• Medullary thyroid cancer does not absorb iodine, so it is not a candidate for this treatment; surgery and targeted therapy are the mainstay instead.

In what specific situations is RAI therapy given?

• In high-risk thyroid cancer, after total thyroidectomy and lymph node dissection, RAI therapy may be added depending on recurrence risk. In other words, the typical indications are when there is a risk of recurrence after total thyroidectomy, or when iodine-avid metastasis has been confirmed.
• The criterion for deciding whether to use this treatment is risk classification rather than the stage number alone. Tumor size, whether it has spread outside the thyroid, the number and size of lymph node metastases, vascular invasion, histologic type, and whether surgery achieved complete removal are all combined to classify recurrence risk as low, intermediate, or high. This classification determines the extent of surgery, whether RAI therapy is needed, and the interval for follow-up afterward.
• Low-risk patients are often spared this treatment, while it is considered for intermediate-risk and above. Since it is not needed for everyone, skipping RAI when recurrence risk is low is the standard approach.

What is the sequence of steps before and after treatment?

1. Step 1 — After total thyroidectomy, recurrence risk is assessed based on pathology results.
2. Step 2 — A low-iodine diet is followed for a set period before treatment.
3. Step 3 — Radioactive iodine is administered, which may require isolated inpatient admission.
4. Step 4 — A whole-body scan after treatment confirms where the iodine was absorbed.
5. Step 5 — Thyroid hormone dosage is adjusted, and thyroglobulin levels are tracked to monitor for recurrence.

FAQ — Does radiation remain in my body afterward, meaning I can't be near family?

Because RAI involves putting a radioactive substance inside the body — unlike conventional external beam radiation therapy — contact restrictions for a certain period may be necessary. This is why isolation inpatient time is built into the schedule, and patients are given specific guidance on both the pre-treatment low-iodine diet and the duration of contact restrictions.

FAQ — What side effects occur, and how long do they last?

Dry mouth, salivary gland swelling, altered taste, and nausea are common parts of the course. After total thyroidectomy, patients may go through weeks to months of an adjustment period — involving fatigue, weight changes, and feeling cold — while hormone dosage is being calibrated. This can occur in anyone who has had a total thyroidectomy, regardless of whether RAI therapy was given.

FAQ — What if radioactive iodine stops working?

For metastatic thyroid cancer that has become radioactive-iodine-refractory, targeted therapy is considered. If a specific gene alteration (such as RET, NTRK, or BRAF) is identified, a matching targeted drug is considered. Medullary thyroid cancer does not absorb iodine from the start, so surgery and targeted therapy are the primary approach from the outset.

Sources and Notes

• This article was written based on the Thyroid Cancer Note (National Cancer Registration Statistics 2019–2023, Korea Central Cancer Registry, National Cancer Center Korea; SEER 2016–2022; NCCN Guidelines for Patients).
• This content is intended to provide general medical information, and actual diagnosis, treatment methods, and outcomes may vary depending on individual circumstances. Accurate diagnosis and treatment must be determined through consultation with a medical professional.